FDA Inspection
Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma ServicesLyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services – FDA Inspection, Feb 15, 2017
Record Details
This FDA Inspection record concerns Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services, with an inspection on February 15, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 15, 2017
- Product Type
- Drugs
View Company Profile
ID · 7a8bda05-f6fb-4847-9c01-4422c91d436c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1002975
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
8| Date | Classification | Office | Project area |
|---|---|---|---|
| June 10, 2026 | Not classified | New England District Office | Drug Quality Assurance |
| May 24, 2024 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
| September 27, 2023 | OAI | New England District Office | |
| December 7, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services
- FDA Inspection 1321518 - 2026-06-10
- FDA Inspection 1239754 - 2024-05-24
- FDA Inspection 1218916 - 2023-09-27
- FDA Inspection 1074079 - 2018-12-07
- FDA Inspection 1003136 - 2017-02-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.